Does ALPRAZOLAM Cause Ventricular hypertrophy? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Ventricular hypertrophy have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.0% of all adverse event reports for ALPRAZOLAM.
5
Reports of Ventricular hypertrophy with ALPRAZOLAM
0.0%
of all ALPRAZOLAM reports
5
Deaths
1
Hospitalizations
How Dangerous Is Ventricular hypertrophy From ALPRAZOLAM?
Of the 5 reports, 5 (100.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which ALPRAZOLAM Alternatives Have Lower Ventricular hypertrophy Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE